Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT06430099
  4. Details
NCT06430099 Clinical Trial

Rate of Blood Pressure Control Among Hypertensive Patients With Hemodialysis in Sohag University Hospital

Hypertension Clinical Trial

Official title:
Rate of Blood Pressure Control Among Hypertensive Patients With Hemodialysis in Sohag University Hospital

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06430099
Other study ID # Sohagu.
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 24, 2024
Est. completion date December 20, 2024

Study information
Verified date May 2024
Source Sohag University
Contact Hager A Mohamed, M.B.B.CH
Email hagerabdo@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The goal of this Cross-sectional study is to detect hypertensive patients with hemodialysis in Sohag University Hospital and controlled patients and noncontrolled patients. The main questions it aims to answer are: 1. What is the pattern of blood pressure control among patients receiving hemodialysis? 2. What are factors associated with successful blood pressure control? 3. What is the level of patient knowledge and awareness regarding blood pressure management? 4. What are the challenges and barriers faced by patients in achieving optimal blood pressure control? Participants Blood pressure calculated by taking the average of three consecutive days measurement.

Description:

1. Survey Type: Cross-sectional study. 2. Target Population: Patients undergoing hemodialysis. 3. Sample Size: The target sample size are all hypertensive patients in Sohag university hospital dialysis unit 4. Survey Method: person to person interview in dialysis units will be used for data collection. Blood pressure calculated by taking the average of three consecutive days - 1st day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis). - 2nd day (Inter Dialytic Day): - Blood pressure will be measured two times (AM, PM). - 3rd day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis).

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date December 20, 2024
Est. primary completion date December 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants must be - 18 years or older. - currently receiving hemodialysis. - Hypertensive patients. Exclusion Criteria: - patients under 18 years old. - Patients stopped hemodialysis. - Patients with ESRD not receiving hemodialysis.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Egypt Faculty of Medicine Sohag University Sohag

Sponsors (1)
Lead Sponsor Collaborator
Hager Abdo Mohamed

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Garcia-Llana H, Remor E, Selgas R. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema. 2013 Feb;25(1):79-86. doi: 10.7334/psicothema2012.96. — View Citation

Joshi VD. Quality of life in end stage renal disease patients. World J Nephrol. 2014 Nov 6;3(4):308-16. doi: 10.5527/wjn.v3.i4.308. — View Citation

Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK; Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002 Jul;62(1):199-207. doi: 10.1046/j.1523-1755.2002.00411.x. — View Citation

Susel J, Batycka-Baran A, Reich A, Szepietowski JC. Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol. 2014 May;94(3):276-81. doi: 10.2340/00015555-1749. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of blood pressure control among hypertensive patients with hemodialysis in Sohag University Hospital with hemodialysis in Sohag University Hospital 3 days
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A